Drugs / FE200440
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00209326 | Nov 2003 → Jul 2006 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FE200440 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00209326 ↗ |
| Route | Intravenous | “administered intravenously” NCT00209326 ↗ |